MECHANISM OF PEPTIDE LOADING ONTO HUMAN MHC CLASS II MOLECULES
MECHANISM OF PEPTIDE LOADING ONTO HUMAN MHC CLASS II MOLECULES
批准号:
8361725
负责人:
Kai W Wucherpfennig
金额:
$0.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2012-03-31
关键词:
BindingCLIP peptideExcisionFundingGoalsGrantHistocompatibility Antigens Class IIHumanLeftMolecularN-terminalNational Center for Research ResourcesPeptide HydrolasesPeptidesPrincipal InvestigatorResearchResearch InfrastructureResourcesSourceUnited States National Institutes of Healthbasecostinsightinvariant chainmicrobialstructural biology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The goal of the project is to determine the mechanisms of peptide loading onto human MHC class II molecules. MHC class II molecules bind peptides very tightly, with half-lives of several days to weeks. Empty MHC class II molecules have a tendency to aggregate and they assemble in the ER with invariant chain, which occupies the binding groove like a peptide. In the endosomal peptide loading compartment, invariant chain is degraded by a set of proteases, leaving the CLIP peptide of invariant chain in the groove. Removal of the CLIP peptide requires the action of HLA-DM and makes the binding groove vacant for binding of microbial peptides. We have defined the molecular requirements for the interaction of MHC class II molecules with HLA-DM. We found that HLA-DM binding required release of the N-terminal part of the peptide. Based on this insight, we are now attempting to characterize this interaction at a structural level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
-
批准号:10380449
-
项目类别:
-
资助金额:$12.57万
-
财政年份:2021
-
负责人:Kai W Wucherpfennig
-
依托单位:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
-
批准号:10210225
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
-
批准号:10029035
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
-
批准号:10210221
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
-
批准号:10224146
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
-
批准号:10400167
-
项目类别:
-
资助金额:$47.57万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
-
批准号:10477984
-
项目类别:
-
资助金额:$35.2万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
-
批准号:10668947
-
项目类别:
-
资助金额:$47.57万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
-
批准号:10684029
-
项目类别:
-
资助金额:$35.2万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
-
批准号:10684050
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
-
批准号:10477994
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2020
-
负责人:Kai W Wucherpfennig
-
依托单位:
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
-
批准号:10524130
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2019
-
负责人:Kai W Wucherpfennig
-
依托单位:
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
-
批准号:10359199
-
项目类别:
-
资助金额:$51.04万
-
财政年份:2019
-
负责人:Kai W Wucherpfennig
-
依托单位:
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
-
批准号:10596611
-
项目类别:
-
资助金额:$51.04万
-
财政年份:2019
-
负责人:Kai W Wucherpfennig
-
依托单位:
Cancer Immunology Training Grant
-
批准号:9404561
-
项目类别:
-
资助金额:$1.02万
-
财政年份:2016
-
负责人:Kai W Wucherpfennig
-
依托单位:
Cancer Immunology Training Grant
-
批准号:9315112
-
项目类别:
-
资助金额:$47.23万
-
财政年份:2016
-
负责人:Kai W Wucherpfennig
-
依托单位:
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
-
批准号:10227095
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2013
-
负责人:Kai W Wucherpfennig
-
依托单位:
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
-
批准号:10658861
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2013
-
负责人:Kai W Wucherpfennig
-
依托单位:
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
-
批准号:10443722
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2013
-
负责人:Kai W Wucherpfennig
-
依托单位:
Novel Tools for Immune Monitoring in Autoimmune Diseases
-
批准号:8316145
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2011
-
负责人:Kai W Wucherpfennig
-
依托单位: